SCHEMBL12027322

SCHEMBL12027322

Nc1cc(CN2CCOCC2)ccc1NC(=O)c1n[nH]cc1NC(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNH2 Q12809 6/20 0.46
▸ ACHE P22303 1/20 0.42
▸ GALR3 O60755 1/20 0.42
▸ LMNA P02545 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ HDAC1 Q13547 2/20 0.42
▸ HIF1A Q16665 3/20 0.41
▸ EPAS1 Q99814 3/20 0.41
▸ CDK2 P24941 2/20 0.41
▸ FLT3 P36888 1/20 0.41
▸ CCNA1 P78396 1/20 0.41
▸ AURKA O14965 1/20 0.41
▸ CDK1 P06493 1/20 0.41
▸ CCNB1 P14635 1/20 0.41
▸ AURKB Q96GD4 1/20 0.41
▸ GSK3B P49841 1/20 0.40
▸ DYRK1A Q13627 1/20 0.40
▸ F10 P00742 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10240094 0.90 KCNH2 (0.48) KCNH2ACHEGALR3LMNAMAPT
SCHEMBL546189 0.90 KCNH2 (0.49) KCNH2ACHEHDAC1HIF1AEPAS1
SCHEMBL546288 0.87 KCNH2 (0.44) KCNH2ACHEGALR3LMNAMAPT
SCHEMBL11888568 0.87 KCNH2 (0.44) KCNH2ACHEMAPTHDAC1GSK3B
SCHEMBL10240088 0.83 KCNH2 (0.46) KCNH2LMNAMAPTMAPK1SMN1; SMN2
SCHEMBL546646 0.82 KCNH2 (0.47) KCNH2ACHEMAPK1SMN1; SMN2HDAC1
SCHEMBL546615 0.80 KCNH2 (0.43) KCNH2MAPTMAPK1SMN1; SMN2HDAC1
SCHEMBL11888569 0.79 KCNH2 (0.42) KCNH2ACHEMAPTMAPK1SMN1; SMN2
SCHEMBL15883827 0.77 NPC1 (0.57) KCNH2LMNAMAPTMAPK1SMN1; SMN2
SCHEMBL12002312 0.76 ACKR3 (0.50) KCNH2LMNASMN1; SMN2HIF1AEPAS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2395000-A1 Benzimidazole compounds that modulate the activity of CDK, GSK and aurora kinases Astex Therapeutics Limited (GB) 2011-12-14 — — EP disclosed
Send feedback